Merck and Moderna initiate phase 3 study evaluating V940
V940-001 is the first phase 3 study of a planned comprehensive clinical development program being initiated following the positive…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indoco’s Baddi facility receives GMP certification from EU Health Authority
The Agency had conducted an inspection at Indoco’s manufacturing facility for solid oral dosage form from April 20 - 24, 2023
Shingles vaccine reduces risk of stroke and heart attack from virus: Study
Results are based on analysis of data from 278,375 adults in New Zealand who got the vaccine between April 2018 and July 2021.…
Lupin receives approval from TGA Australia for Tiotropium dry powder
The product will be manufactured at Lupin’s Pithampur facility in India
GSK announces financial results for Q2 2023
Profit After Tax (PAT) for the quarter at Rs 131 crores grew by ~ 13 per cent
Octet® BLI Systems: Making CQA measurement rapid and efficient
Critical quality attributes (CQAs) are essential measurements that include product-specific attributes such as size, charge, and…
Pharma industry headwinds in remission: ICRA
Revenues of ICRA’s sample set to grow by 7-9 per cent in FY2024; OPM to stabilise at 20.5-21.5 per cent in FY2024
BSV launches ART Act Readiness Assessment Program with Bureau Veritas (India)
It will enable ART centres/clinics to implement the requirements of the Assisted Reproductive Technology Regulations, 2021 for…
AstraZeneca’s Dapagliflozin gets extended indication approval from DCGI to treat heart failure in…
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted…
M&A activity of pharma CMOs will continue despite challenging borrowing environment: GlobalData
CMOs showed an increasing reluctance to take on debt in 2022. Even still, large CMOs made acquisitions of companies and facilities…